The Crashing Patient with Critical Aortic Stenosis (2022)

A 90-year-old male with a past medical history of severe aortic stenosis, heart failure with reduced ejection fraction, and chronic kidney disease presents with shortness of breath. His vital signs are as follows: HR 112, BP 85/60, RR 28, SpO2 85% on room air. Bedside ultrasound reveals diffuse B lines consistent with pulmonary edema, and he is placed on non-invasive positive pressure ventilation.

What is the best way to manage this patient, particularly if he continues to decompensate?

Critical aortic stenosis (AS) is the single most problematic valvular disease we encounter in the emergency department. Patients with critical AS have a fixed cardiac output and cannot meaningfully increase cardiac output to meet the physiologic demands of critical illness. Avoiding systemic hypotension, maintaining sinus rhythm, and avoiding excessive tachycardia are therefore the cornerstones of resuscitation.

Background

AS is the third most common cardiovascular disease in the developed world, eclipsed only by systemic hypertension and coronary artery disease. The prevalence in the general population is 0.4%, but increases to 9.8% in octogenarians, with an overall prevalence of 2.8% in adults older than 75 years of age.1,2 Valve replacement, either surgical or catheter directed (ie, transcatheter aortic valve replacement, or TAVR), is the mainstay of treatment for advanced disease.

(Video) The Crashing Aortic Stenosis Patient

In a normal adult, the aortic valve area measures 2.6 to 3.5 cm2. AS becomes hemodynamically significant when aortic valve area approaches <1 cm2. As the valve becomes tighter, the pressure gradient across the valve increases. A pressure gradient >50 mmHg indicates severe disease.3-5 However, it is important to note that a substantial proportion of patients with severe and critical AS have a low gradient, which most frequently results from the decreased stroke volume associated with advanced disease.

Hemodynamically significant AS must be on the differential in the undifferentiated patient presenting with acute pulmonary edema, syncope, or cardiogenic shock, particularly if they are elderly. In addition to the identification of a systolic ejection murmur, bedside echocardiography can help screen patients. In fact, qualitative assessment of the aortic valve from the parasternal long and short axis views has been shown to be 75% sensitive and 93% specific for the diagnosis of severe AS among trained emergency medicine providers.6

Physiology Primer

The stenotic aortic valve results in a buildup of pressure inside the left ventricle and a comparably lower pressure in the aortic root, resulting in low coronary perfusion pressure. This leaves the left ventricle uniquely susceptible to ischemia, which reduces cardiac output and promotes further ischemia.7 Systemic hypotension reduces coronary perfusion pressure, and excessive tachycardia increases myocardial oxygen demand; both contribute to a self-perpetuating cycle of ischemia and cardiogenic shock (see Figure).

The left ventricle hypertrophies in critical AS in response to chronically increased afterload. A stiff, hypertrophied left ventricle requires high filling pressures, and the “atrial kick” of sinus rhythm to fill in diastole. Hypovolemia and supraventricular tachyarrhythmias (eg, atrial fibrillation) dramatically reduce left ventricular preload and are tolerated poorly in this patient population.8 Excessive tachycardia not only promotes ischemia, but also reduces time spent in diastole for left ventricular filling.

(Video) How should I treat a patient with severe aortic stenosis and heavily calcified CAD?

Vasopressor Management

Phenylephrine is the vasopressor of choice in treating the hypotensive patient with AS. Using an agent that solely increases afterload is initially counterintuitive. It is important to recognize that the massive afterload of aortic stenosis is at the level of the aortic valve, with little contribution from the systemic vasculature. As a pure alpha-1 agonist, phenylephrine increases diastolic blood pressure and thus improves coronary perfusion. Phenylephrine also may result in a reflex bradycardia — a favorable pharmacodynamic property for its use in aortic stenosis.9 Norepinephrine is, similarly, a reasonable choice. Avoid epinephrine as a first line agent given its strong beta-1 agonism and propensity to promote tachycardia and increase myocardial oxygen demand.

Fluid Management

The tight aortic valve increases left-sided pressures and can lead to pulmonary congestion. However, patients with AS also have diastolic dysfunction and depend on preload to fill the left ventricle and maintain cardiac output. Decisions on fluid administration are challenging in this patient population and should be made in the context of the clinical scenario.

Consider the hemodynamically unstable patient with critical AS who you
are preparing to intubate. Any concern regarding pulmonary congestion is superseded by the need to optimize preload prior to induction. Assuming
the patient is not on the tail end of the Frank-Starling curve, temporarily infusing crystalloids to optimize preload and stave off peri-intubation hypotension is a good idea.

(Video) Understanding Aortic Stenosis with Dr. Marc Gillinov

Now, consider a stable patient with critical AS who is having a slow GI bleed. So long as there are no hemodynamic perturbations to necessitate rapid replacement of blood products, the clinical scenario calls for a cautious fluid administration strategy because the patient is prone to developing pulmonary edema. Administer small volumes, and frequently reassess for signs of congestion (eg, B lines on lung ultrasound).

The Crashing Patient with Critical Aortic Stenosis (1)

Intubation

Patients with critical AS depend on adequate left ventricular preload to maintain cardiac output. Both induction agents and positive pressure ventilation acutely drop left ventricular preload, and place patients with critical AS at risk for peri-intubation hemodynamic collapse. Hemodynamic optimization prior to induction, adequate monitoring, and selection of an induction agent with a favorable hemodynamic profile are the mainstays of safe intubation.

As you prepare to intubate, have push-dose phenylephrine at the bedside (or infusing). Prior to induction, the patient should be preload optimized. If there is any uncertainty regarding volume status, err on the side of fluid administration. Even short periods of systemic hypotension can be devastating and are easily missed by a periodically cycling non-invasive blood pressure cuff. If time allows (eg, the urgent-not-emergent intubation), consider placing an arterial line prior to induction to decrease response time to systemic hypotension.

(Video) IGNITE! Session 1- The Crashing Patient with Acute RV Failure

Patients with critical AS depend on the atrial kick of sinus rhythm for diastolic filling. If you are preparing to intubate a hemodynamically tenuous patient in new atrial fibrillation (or any SVT for that matter), consider cardioversion prior to induction.

Etomidate is the RSI induction agent of choice in patients with AS, because it is both hemodynamically stable and comes with a generally favorable side effect profile. Propofol is a profound vasodilator and can acutely drop preload and promote hemodynamic collapse. Ketamine promotes tachycardia — an unfavorable property in patients with AS.

Case Conclusion

The patient was placed on a phenylephrine infusion, and preload was optimized prior to intubation. After intubation he was admitted to the CCU, where he was cautiously diuresed throughout the next week. He responded well to medical management and was extubated without event. Ultimately, he was transferred to another institution for TAVR and had a full recovery.

Definitive management of AS is generally surgical or endovascular, and is informed by formal echocardiography. However, ED providers will no doubt encounter patients with previously unrecognized AS. Physical exam and bedside echocardiography can suggest the diagnosis of AS when little background clinical data is available. Patients with hemodynamically significant AS are challenging to manage in the resuscitation phase. Avoid excessive tachycardia, maintain sinus rhythm, optimize preload, and treat hypotension aggressively with phenylephrine.

(Video) CrashingPatient: Tracheostomy Disasters

References


  1. Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. the tromso study. Heart. 2013;99(6):396-400.

  2. Lindman BR, Clavel M, Mathieu P, et al. Calcific aortic stenosis.Nature Reviews Disease Primers. 2016;2:nrdp20166.

  3. Frank S, Johnson A, Ross J,Jr. Natural history of valvular aortic stenosis.Br Heart J. 1973;35(1):41-46.

  4. Kennedy KD, Nishimura RA, Holmes DR, Bailey KR. Natural history of moderate aortic stenosis.J Am Coll Cardiol. 1991;17(2):313-319.

  5. Turina J, Hess O, Sepulcri F, Krayenbuehl H. Spontaneous course of aortic valve disease.Eur Heart J. 1987;8(5):471-483.

  6. Alzahrani H, Woo MY, Johnson C, Pageau P, Millington S, Thiruganasambandamoorthy V. Can severe aortic stenosis be identified by emergency physicians when interpreting a simplified two-view echocardiogram obtained by trained echocardiographers?Critical ultrasound journal. 2015;7(1):5.

  7. Hensley FA, Martin DE, Gravlee GP.A practical approach to cardiac anesthesia.Lippincott Williams & Wilkins; 2012.

  8. Horak J, Weiss S. Emergent management of the airway: New pharmacology and the control of comorbidities in cardiac disease, ischemia, and valvular heart disease.Crit Care Clin. 2000;16(3):411-427.

  9. Goertz AW, Lindner KH, Schutz W, Schirmer U, Beyer M, Georgieff M. Influence of phenylephrine bolus administration on left ventricular filling dynamics in patients with coronary artery disease and patients with valvular aortic stenosis.Anesthesiology. 1994;81(1):49-58.

FAQs

What is critical aortic stenosis? ›

Aortic stenosis is one of the most common and serious valve disease problems. Aortic stenosis is a narrowing of the aortic valve opening. Aortic stenosis restricts the blood flow from the left ventricle to the aorta and may also affect the pressure in the left atrium.

How do you treat hypotension with severe aortic stenosis? ›

Phenylephrine is the vasopressor of choice in treating the hypotensive patient with AS. Using an agent that solely increases afterload is initially counterintuitive.

When is aortic stenosis an emergency? ›

If you experience more severe symptoms of aortic valve stenosis or aortic valve regurgitation, including chest pain, fainting, heart palpitations, or shortness of breath, contact your doctor, call 911, or go to the nearest emergency department immediately.

What is done to treat a patient with severe aortic stenosis? ›

The only definitive treatment for aortic stenosis in adults is aortic valve replacement, performed surgically or percutaneously. The development of symptoms due to aortic stenosis provides a clear indication for replacement.

What are the three major symptoms of aortic stenosis? ›

Aortic Stenosis Symptoms
  • Chest pain: You might feel tightness in your lungs and chest, especially with physical activity.
  • Fatigue: You may feel extreme exhaustion during increased activity.
  • Shortness of breath: You may have a hard time breathing deeply, especially after being active.

Can aortic stenosis cause sudden death? ›

Sudden cardiac death (SCD) is a significant concern in asymptomatic patients with aortic stenosis (AS) with a reported incidence of up to 3%/year. However, whether AS alone puts patients at risk independent of non-valve related factors, including coronary heart disease, is unclear.

What is the prognosis for severe aortic stenosis? ›

Severe symptomatic aortic stenosis is associated with a poor prognosis, with most patients dying 2–3 years after diagnosis.

Which vasopressor is best for aortic stenosis? ›

In hypotensive patients with aortic stenosis,Phenylephrine is the vasopressor choice.

When is aortic stenosis considered severe? ›

A recent report shows that asymptomatic or minimally symptomatic patients with severe AS and MPG ≥60 mm Hg at diagnosis are at high risk of death during follow‐up with medical and surgical management compared with those with MPG <60 mm Hg.

Does aortic stenosis affect the brain? ›

Severe aortic stenosis can limit the amount of blood that reaches the brain and the rest of the body.

Can aortic stenosis cause stroke? ›

Aortic valve stenosis is associated with significantly increased risk of ischemic stroke compared with the background population and adds additionally to the risks in patients with atrial fibrillation.

What are the stages of aortic stenosis? ›

The 2020 ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease categorize aortic stenosis into four stages, including: risk of AS (Stage A), progressive hemodynamic obstruction (Stage B), asymptomatic severe AS (Stage C, with substages C1 and C2), and symptomatic severe AS (Stage D, with ...

How fast does aortic stenosis progress? ›

The present observations serve principally to indicate that progression does occur, that progression from noncritical to critical aortic stenosis can occur in less than five years, and that this is very likely to be found when patients with progressive symptoms and electrocardiographic changes are restudied.

Can aortic stenosis cause cardiogenic shock? ›

Rationale: Cardiogenic shock secondary to aortic stenosis (AS) is a challenging problem owing to the high mortality associated with treatment, and successful treatment of such patients has been rare.

How long can you live with severe aortic stenosis? ›

Severe symptomatic aortic stenosis is associated with a poor prognosis, with most patients dying 2–3 years after diagnosis.

At what point does aortic stenosis require surgery? ›

Under current guidelines,4,5 the onset of symptoms of exertional angina, syncope, or dyspnea in a patient who has severe aortic stenosis is a class I indication for surgery—ie, surgery should be performed.

How is severity of aortic stenosis determined? ›

The severity of aortic stenosis is determined by measuring the aortic valve area (AVA) and calculating the pressure gradient between the left ventricle and the aorta on echocardiography. Aortic stenosis is described as mild, moderate, severe or critical based on these measurements.

How quickly does aortic stenosis progress? ›

The present observations serve principally to indicate that progression does occur, that progression from noncritical to critical aortic stenosis can occur in less than five years, and that this is very likely to be found when patients with progressive symptoms and electrocardiographic changes are restudied.

Videos

1. Crashing Patient Medical- 3rd Quarter OMD Protocol Training 2020
(Fort Worth Fire Department Training)
2. Aortic Stenosis: What You Need to Know
(SoutheastHEALTH)
3. Welcome to Final Year. Aortic Stenosis and Aortic Regurgitation.
(Intelligent Finals)
4. What is aortic stenosis? - Dr. Tom Talks
(BioDigital, Inc.)
5. TAVR for the treatment of aortic stenosis - Lila's Good Health
(Saint Joseph Mercy Health System)
6. Aortic Stenosis and General Valvular Principles with Dr. Brown
(UofL Internal Medicine Lecture Series)

You might also like

Latest Posts

Article information

Author: Roderick King

Last Updated: 10/29/2022

Views: 5647

Rating: 4 / 5 (51 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Roderick King

Birthday: 1997-10-09

Address: 3782 Madge Knoll, East Dudley, MA 63913

Phone: +2521695290067

Job: Customer Sales Coordinator

Hobby: Gunsmithing, Embroidery, Parkour, Kitesurfing, Rock climbing, Sand art, Beekeeping

Introduction: My name is Roderick King, I am a cute, splendid, excited, perfect, gentle, funny, vivacious person who loves writing and wants to share my knowledge and understanding with you.